Nasser Davarzani

Circulating Biomarkers of Distinct Pathophysiological Pathways in Heart Failure with Preserved vs. Reduced Left Ventricular Ejection Fraction

Sandra Sanders‐van Wijk, Vanessa van Empel, Nasser Davarzani et al. · European Journal of Heart Failure · 2015 · 261 citations · Full text

Life Sciences, Cardiology, Physiology +14

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the <scp>MRC OE</scp>02 oesophageal cancer trial

Nasser Davarzani, Gordon G.A. Hutchins, Nicholas P. West et al. · Histopathology · 2018 · 42 citations · Full text

Medicine, Oncology, Pathology +17

Statistical inference for discrete middle-censored data

Nasser Davarzani, Ahmad Parsian · Journal of Statistical Planning and Inference · 2010 · 22 citations

Natural Sciences, Biostatistics, Mathematics +14

N-Terminal Pro–B-Type Natriuretic Peptide–Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations—Results From TIME-CHF

Nasser Davarzani, Sandra Sanders‐van Wijk, Joël Karel et al. · Journal of Cardiac Failure · 2017 · 18 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive, preventive, and personalized medicine

Nasser Davarzani, Sandra Sanders‐van Wijk, Micha T. Maeder et al. · The EPMA Journal · 2018 · 15 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17